Drug-drug interactions in anti-HCV therapy: a comparison among options available in Italy.

Erratum Following publication of the original article (Le Infezioni in Medicina, 2019, vol:27 (4):pp:239-250) we became aware of the following errors : In table 3a, pag 245, the interaction between GLE/PIB and Omeprazole does not require dosage adjustments and the correct recommendation is A (allowed) instead of NR (not recommended). The original explanation in the text is correct.